Mirtazapine Tablet, Film Coated
Product Images NDC 55154-7297

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-7297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of mirtazapine, showing its fused ring system and nitrogen-containing functional groups consistent with the active ingredient mirtazapine.*
FDA Label Image

15mg Bag Label (Cf56cd8c E0aa Ae8b 38fe 396561abe6bf 00)

15mg Bag Label (Cf56cd8c E0aa Ae8b 38fe 396561abe6bf 00)
Mirtazapine Tablets USP 15 mg film-coated tablets in a unit dose package containing 10 tablets. The label includes storage instructions, warnings about child resistance and institutional use, and pharmacist dispensing instructions. Packaged by Major Pharmaceuticals and distributed by Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.